Form 4 for HUMA Humacyte, Inc.
Accepted 2024-06-03 00:00:00 ET · period of report 2024-05-30 · accession 0001818382-24-000074 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-06-03 | 2024-05-30+ | HUMA | Prichard Heather Ledbetter | COO | S - Sale+OE | $8.15 | -191.5K | 2,625 | -99% | -$1.56M |
| DM | 2024-06-03 | 2024-05-30 | HUMA | Prichard Heather Ledbetter | COO | M - OptEx | $2.75 | +126.9K | 81.4K | New | +$349.5K |
| DM | 2024-06-03 | 2024-05-30 | HUMA | Prichard Heather Ledbetter | COO | M - OptEx | $0.00 | -126.9K | 87.8K | -59% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-30 | S | D | 78,779 | $8.36 | 2,625 | D | — | — | (F1) The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $8.36 to $8.44. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2024-05-30 | M | A | 48,166 | $3.07 | 50,791 | D | — | — | |
| 3 | Common | Common Stock | 2024-05-31 | S | D | 2,625 | $9.41 | 0 | D | — | — | |
| 4 | Common | Common Stock | 2024-05-30 | M | A | 78,779 | $2.56 | 81,404 | D | — | — | |
| 5 | Common | Common Stock | 2024-05-30 | S | D | 61,941 | $7.71 | 2,625 | D | — | — | |
| 6 | Common | Common Stock | 2024-05-30 | S | D | 48,166 | $8.32 | 2,625 | D | — | — | (F2) The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $8.31 to $8.42. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 7 | Derivative | Stock Options (right to buy) | 2024-05-30 | M | D | 78,779 | $0.00 | 0 | D | $2.56 · 2018-12-11 to 2025-12-11 | 78,779 Common Stock | |
| 8 | Derivative | Stock Options (right to buy) | 2024-05-30 | M | D | 48,166 | $0.00 | 87,834 | D | $3.07 · 2024-05-08 to 2032-12-08 | 48,166 Common Stock |